Literature DB >> 12161819

The rabies virus glycoprotein determines the distribution of different rabies virus strains in the brain.

Xiuzhen Yan1, Puliyur S Mohankumar, Bernhard Dietzschold, Matthies J Schnell, Zhen F Fu.   

Abstract

The contribution of rabies virus (RV) glycoprotein (G) in viral distribution in the brain was examined by immunohistochemistry following stereotaxic inoculation into the rat hippocampus. Viruses used in this study include the highly neuroinvasive challenge virus standard strains (CVS-N2C and CVS-B2C) and the nonneuroinvasive attenuated SN-10 strain, as well as SN-10-derived recombinant viruses expressing the G gene from CVS-N2C (RN2C) or CVS-B2C (RB2C). The distribution of recombinant viruses in the brain was similar to those of the parental viruses from which the G was derived. For example, while CVS-B2C- and RB2C-infected neurons were seen preferentially in the hippocampus, cortex, and hypothalamus, CVS-N2C- and RN2C-infected neurons were preferentially found in the hippocampus, cortex, and thalamus. SN-10 infected efficiently almost all the brain regions. To further study the role of the RV G in virus spreading, we examined the distribution of RV antigen in brains infected with a recombinant RV in which the SN-10 G was replaced with vesicular stomatitis virus (VSV) G (SN-10-VG) was examined. The spreading of SN-10-VG to the cortex and the thalamus was drastically reduced, but the number of infected neurons in hippocampus and hypothalamus, particularly the paraventricular nucleus, was similar to the SN-10 virus. This pattern of spreading resembles that of VSV. Together, our data demonstrate that it is the G protein that determines the distribution pattern of RV in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161819     DOI: 10.1080/13550280290100707

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

1.  Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach.

Authors:  K Morimoto; H D Foley; J P McGettigan; M J Schnell; B Dietzschold
Journal:  J Neurovirol       Date:  2000-10       Impact factor: 2.643

2.  Rabies virus quasispecies: implications for pathogenesis.

Authors:  K Morimoto; D C Hooper; H Carbaugh; Z F Fu; H Koprowski; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.

Authors:  X Yan; M Prosniak; M T Curtis; M L Weiss; M Faber; B Dietzschold; Z F Fu
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

4.  Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus.

Authors:  K Morimoto; Y J Ni; A Kawai
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

5.  Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis.

Authors:  B S Huneycutt; I V Plakhov; Z Shusterman; S M Bartido; A Huang; C S Reiss; C Aoki
Journal:  Brain Res       Date:  1994-01-28       Impact factor: 3.252

6.  Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures.

Authors:  K Morimoto; D C Hooper; S Spitsin; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Is the acetylcholine receptor a rabies virus receptor?

Authors:  T L Lentz; T G Burrage; A L Smith; J Crick; G H Tignor
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

8.  Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.

Authors:  C Tuffereau; J Bénéjean; D Blondel; B Kieffer; A Flamand
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

9.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

10.  Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

Authors:  D C Hooper; K Morimoto; M Bette; E Weihe; H Koprowski; B Dietzschold
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

View more
  19 in total

Review 1.  Rabies pathogenesis.

Authors:  Alan C Jackson
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

Review 2.  Neurovirological methods and their applications.

Authors:  P G E Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

3.  Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice.

Authors:  Mutsuyo Takayama-Ito; Naoto Ito; Kentaro Yamada; Nobuyuki Minamoto; Makoto Sugiyama
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

Review 4.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic.

Authors:  James P McGettigan; Roger J Pomerantz; Catherine A Siler; Philip M McKenna; Heather D Foley; B Dietzschold; Matthias J Schnell
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 6.  Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Authors:  Anita Mahadevan; M S Suja; Reeta S Mani; Susarala K Shankar
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 7.  The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.

Authors:  Matthias J Schnell; Gene S Tan; Bernhard Dietzschold
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

Review 8.  Rabies virus receptors.

Authors:  Monique Lafon
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

9.  Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice.

Authors:  Luciana Sarmento; Xia-qing Li; Elizabeth Howerth; Alan C Jackson; Zhen F Fu
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

10.  The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread.

Authors:  Rojjanaporn Pulmanausahakul; Jianwei Li; Matthias J Schnell; Bernhard Dietzschold
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.